Displaying 1 - 12 of 26
Immune-Mediated and Cholestatic Diseases

GSK: "Investigating IBAT inhibition in itch – a new tool for an age-old problem?" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: "Practical tips towards providing holistic care to patients with PBC" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Ipsen: "Scratching beyond the surface in PBC: From current unmet medical needs to future prospects" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Mirum Pharmaceuticals, Inc: "Meet the Experts in Cholestatic Liver Disease" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What is the unmet burden of itch from an HCP perspective?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

How can we face itch in the present?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What is the unmet burden of itch from a patient perspective?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

IBAT inhibition: a tool for the future?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What are the unmet needs in PBC according to a patient advocate?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Why is holistic care important for patients with PBC?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What can we learn about holistic care to manage cholestatic pruritus in PBC from a UK healthcare setting?

Webcasts
View